DSDavid Segal

David Segal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Segal has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Value of IGF-1 for childhood growth hormone deficiency

    by Kerry Marran, David Segal, Peter Kamerman, Daniel Saksenberg


  • Open Access

    Development and evaluation of the Flourish Diabetes Programme

    by Sylvia Kruger, Elmari Deacon, Esme van Rensburg, David Segal

    Background: Adolescents with type 1 diabetes face unique challenges in adapting to closed-loop technology. Positive psychology interventions may aid in promoting psychological adjustment, enhancing well-being and supporting the effective use of this technology. Aim: This study describes the development, content and evaluation of a positive psychology intervention, the Flourish Diabetes Programme, to facilitate adjustment to closed-loop technology among adolescents with type 1 diabetes. Setting: The Flourish Diabetes Programme is an online, interactive intervention aimed at adolescents living with type 1 diabetes who use closed-loop technology. Methods: The development of the programme was informed by qualitative research with adolescents, qualitative document analysis and the design and development model. The Delphi method was used to evaluate the intervention, where 11 experts provided feedback to refine and enhance the programme. Results: Feedback from the Delphi panel informed the refinement and finalisation of the Flourish Diabetes Programme, contributing to an evidence-based and user-centred intervention. Conclusion: The Flourish Diabetes Programme is a tailored online resource designed to support adolescents in adapting to closed-loop technology. Insights from the Delphi panel helped shape the programme into a practical tool for promoting positive adjustment. Contribution: This intervention is the first step in developing effective, evidence-based resources to help adolescents with type 1 diabetes manage new medical technologies, specifically closed-loop systems, using positive psychological principles.


  • Open Access

    Continuous glucose monitoring empowers adolescents to take responsibility of diabetes management

    by Letitia Williams, Elmarí Deacon, Esmé Van Rensburg, David Segal

    Background: Managing diabetes is especially challenging for adolescents, and they often struggle to believe they can manage the condition. Illness perception has been widely associated with better diabetes management outcomes, but the influence of continuous glucose monitoring (CGM) on adolescents has been largely neglected.Aim: The study aimed to explore the illness perception of a group of adolescents living with type 1 diabetes (T1D) using CGM.Setting: The study was conducted at a medical centre that provides diabetes care services to youth living with T1D in Parktown, South Africa.Methods: A qualitative research approach using semi-structured online interviews was used to gather data that was thematically analysed.Results: Themes emerging from the data confirmed that CGM creates a sense of control over diabetes management as blood glucose measures were more visible. A sense of normalcy was established as CGM influences a new routine and a way of life, integrating diabetes into a young person’s identity. Despite the users’ awareness of being different due to diabetes management, CGM assisted in creating a sense of belonging, contributing to developing a better quality of life.Conclusion: Findings of this study support the use of CGM as a means of empowering adolescents struggling with diabetes management to achieve better treatment outcomes. The important role of illness perception in facilitating this change was also evident.Contribution: By listening to the adolescent’s voice, CGM was identified as a possible intervention to empower adolescents to improve diabetes management.


  • Fetal Death Associated with Asymptomatic Intrauterine Candida albicans Infection and a Retained Intrauterine Contraceptive Device

    by David Segal, Josef Gohar, Mahmoud Huleihel, Moshe Mazor

    We present a case of intrauterine fetal death at 18 weeks of gestation associated with a retained intrauterine contraceptive device and asymptomatic intraamniotic and fetal infection by Candida albicans. The infection was verified by histopathologic examination of the placenta and umbilical cord, growth of C. albicans in samples of amniotic fluid and the presence of high levels of IL-6 in the amniotic fluid.